Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000146

Drug Information
NameCefotaxime    
Synonymscefotaxime; Cefotaxima; AC1OC9NB; Spectrum4_000268; SPBio_000138; Prestwick0_000139; AC1L9UKL; STK383264; BSPBio_000218; Cefotaximum [INN-Latin]; CE3; Claforan; HMS2090M11; SPBio_002157; KBioGR_000736; Cefotaxime (INN); Lopac0_000278; C16H17N5O7S2; BSPBio_001961; AC1NSF5T; CID5742673; Spectrum_000108; BRD-K99586414-236-02-3; DivK1c_000767; 63527-53-7; KBio2_000548; CID6604086; AC1O7G8N; BIDD:GT0681; Cefotaxim; Cephotaxime; AC1NX3QV; CID5916965; MolPort-006-834-754; DB00493; KBio2_003116; Cefotaximum; KBioSS_000548; Prestwick1_000139; AC1NZU9Q; AC1L1E42; Cefotaxim Hikma (TN); Spectrum2_000119; RU 24662; Claforan (*Sodium salt*); Cefotaxim Hikma; CID7566336; AC1O712I; CHEBI:204928; Ru-24756; NCGC00021126-01; KBio3_001181; CID6540461; KBio1_000767; Spectrum3_000331; AC1NUIF8; Klaforan; KBio2_005684; NINDS_000767; Cefotaxime [INN:BAN]; Prestwick2_000139; C06885; EINECS 264-299-1; Spectrum5_000667; D07647; MolPort-002-339-742; LS-187246; Cefotaxima [INN-Spanish]; MolPort-005-934-578; AC1NSF6T; 64485-93-4 (mono-hydrochloride salt); CID9868614; AKOS003286450; LS-149920; AC-217; IDI1_000767; CID5479527; CHEMBL102; Cefotaxime acid; UNII-N2GI8B1GK7; BRD-K78364995-236-03-5; CID5361354; CID2632; CID5361298; 60846-21-1; BPBio1_000240; CID6914272; Cephotaxim; 63527-52-6; Prestwick3_000139; CID456256    
Trade NameClaforan    
CompanyRoussel Uclaf    
IndicationBacterial InfectionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Bacterial Agents    
CAS NumberCAS 63527-52-6
FormularC16H17N5O7S2    
PubChem Compound IDCID 2632.    
PubChem Substance IDSID 6538280.    
SuperDrug ATC IDJ01DD01;    
SuperDrug CAS ID064485934;    
TargetD-alanyl-D-alanine carboxypeptidaseInhibitor[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 064200 To Reference
Ref 2Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2007 Jun;2:297-307. To Reference
Ref 3Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. Biochemistry. 1995 Jul 25;34(29):9532-40. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543